Dermatomyositis Immunosuppression in Bacillus Calmette-Guerin-Treated Urothelial Cancer
Can J Neurol Sci
.
2023 Jun 2;1-3.
doi: 10.1017/cjn.2023.238.
Online ahead of print.
Authors
Dennis Dimond
1
,
Negar Tehrani
1
,
Athithan Ambikkumar
2
,
Julia Madill
3
,
Karen Naert
4
,
Kristopher D Langdon
4
,
Carlos R Camara-Lemarroy
1
Affiliations
1
Department of Clinical Neurosciences, University of Calgary, Cumming School of Medicine, Calgary, Alberta, Canada.
2
Department of Surgery, Section of Ophthalmology, University of Calgary, Cumming School of Medicine, Calgary, Alberta, Canada.
3
Department of Emergency Medicine, University of Calgary, Cumming School of Medicine, Calgary, Alberta, Canada.
4
Department of Pathology & Laboratory Medicine, University of Calgary, Cumming School of Medicine, Calgary, Alberta, Canada.
PMID:
37264795
DOI:
10.1017/cjn.2023.238
No abstract available
Keywords:
Dermatomyositis; bacillus calmette-guerin; immunosuppression; transition cell carcinoma.